Business
Covalon Announces Expansion of its United States Pediatric Hospital Customer Base
Covalon Announces Expansion of its United States Pediatric Hospital Customer Base ...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n \n \n \n Covalon Announces Expansion of its United States Pediatric Hospital Customer Base\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Covalon's compassionate care technology is quickly becoming a standard of care in more than 17% of pediatric hospitals in the US.\n \n \n \n \n \n MISSISSAUGA, ON\n \n \n ,\n \n \n Sept. 8, 2022\n \n \n /CNW/ - Covalon Technologies Ltd. (the \"Company\" or \"Covalon\") (TSXV: COV) (OTCQX: CVALF) an advanced medical technologies company, today announced it has now grown its pediatric hospital customer base to over 40 pediatric hospitals, which represents more than 17% of\n \n United States\n \n pediatric hospitals.  All these hospitals have adopted at least one of Covalon's patented infection prevention products to help prevent bloodstream and/or surgical site infections and improve patient outcomes. Becoming standard of care in a significant number of pediatric hospitals provides a strong base for Covalon to grow its presence in additional children's hospitals.\n \n \n \n \n \n \n \n \n \n Covalon's suite of compassionate care solutions has been designed to treat the most vulnerable patients and has been successful in improving the standard of care in key pediatric hospitals. Pediatric patients – from birth to 18 years of age – have a different physiology than adult patients and require tailored medical care that best suits their age and unique medical needs. There are more than 250 pediatric hospitals in\n \n the United States\n \n , and they provide over 95% of transplantations, cancer programs, and tertiary care to children.\n \n \n \"It is not a mystery why 8 of the top 10 pediatric hospitals for cancer treatment in\n \n the United States\n \n are using Covalon products,\" said\n \n Brian Pedlar\n \n , CEO of Covalon. \"Our products are specifically designed to help these patients heal better and safer, as recognized by health care providers that have dedicated themselves to the healing of some of our most vulnerable patients ȁ...